About IDDI

Clinical Trial Services : Biostatistics and eClinical Services

IDDI is a leading, therapy-focused data services CRO providing expert clinical trial services: Biostatistics and eClinical Services to ensure you clinical data is ready for submission. We combine advanced biostatistics, regulatory and medical expertise, and innovative integrated eClinical solutions to increase efficiency and mitigate risks throughout the drug development process.

FUNCTIONAL SERVICES FOR CLINICAL RESEARCH IN ALL CLINICAL TRIAL PHASES

Founded in 1991, IDDI is a privately-held company which has stayed faithful to the vision of its founder and eminent statistician, Marc Buyse ScD, since day one.

clinical trial services

Download Service Flyer


Clinical Trial Services

  • Study Design: optimal design of your trials, taking into account the target population, the choice of comparators and the most efficient endpoints
  • Randomization and drug supply (IRT): biostatistics-driven IRT that allows implementation of any complex randomization scheme and integration with EDC
  • Electronic Data Capture (EDC): real-time data capture to ensure quality data improving the speed and reliability of clinical trials. Integrated with IWRS
  • Clinical Data Management: end-to-end comprehensive data management focusing on the accuracy of clinical data and CDISC regulatory compliance
  • Biostatistics: significant efficiency in clinical trials achieved through advanced biostatistics. From study conception to reporting, IDDI biostatisticians are involved in every step of the clinical trial process.
  • Biomarker validation: best-in-class statistical methods to validate biomarkers – Diagnostics/IVD
  • Medical writing: our medical writers can assist at any point in the product development lifecycle across all clinical trial phases
  • Full CRO services with selected partners.     

A Therapy-focused Clinical Research Organization:                                                                                                                                                                                                                                           


OUR MISSION

IDDI’s mission is to optimize the clinical development of drugs, biologicals, biomarkers and devices, using a unique combination of advanced biostatistics and innovative clinical data management technology.


IDDI is PASSION SCIENCE & EXPERIENCE

Combining Passion Science and Experience to ensure your Clinical Data is Ready for Submission

PASSION
  • Our dedicated experts have one goal: to get it right the first time! Flexible, responsive, proactive and with scientific backgrounds, our team is our strongest asset (over 100 employees, including 3 MDs, 9 PhDs, and several MScs) As forward thinkers we develop new methodologies and innovative technologies for the success of your clinical trials.
SCIENCE 
  • Statistics is the cornerstone of all our processes and methods. With a scientifically-driven culture, we have always been at the forefront of methodological research. Most of our operations teams have a scientific background. We have a track-record of contributions to the advancement of statistical methodology as a result of our close collaboration with KOLs and investment in R&D.
EXPERIENCE
  • For nearly 30 years, we have successfully supported 1050+ clinical trials and 20 market approvals for 330+ pharmaceutical companies and biotech companies, as well as academic cooperative groups and CROs worldwide. Our valuable therapeutic insight in oncology and ophthalmology, paired with data quality expertise and ability to think ahead has made a critical difference to the outcome of your clinical trials.

 


GLOBAL-REACH BUSINESS WITH OFFICES IN EUROPE AND THE USA

Headquartered in Louvain-la-Neuve (Belgium), with offices in Raleigh (NC), Boston (MA) and San Francisco (CA), our study experience extends over 70 countries in Europe, the Americas, Asia, and Australia.


EXPERIENCE, EXPERTISE, KNOW-HOW

1046
Phase I-IV clinical trials
20
FDA/EMA approvals

Scientific background:

850
Scientific publications
4
Papers quoted in FDA guidance
750
Scientific conferences
26
Scientific webinars